Merck Drops $9.2 Billion on Experimental Flu Drug — Could This Save Its Post-Keytruda Future?
Merck Stuns Wall Street With $9.2 Billion Bet In a jaw-dropping move,…
Johnson & Johnson Shakes Up Healthcare World: Orthopedics Business Set to Break Away in Massive Spin-Off
J&J’s Bold Move: Spinning Off $9.2 Billion Orthopedics Unit into Standalone Powerhouse…